DOI : 10.1055/s-00000034

Klinische Pädiatrie

Issue 06/07 · Volume 227 · November 2015 DOI: 10.1055/s-005-30431


24th Annual Meeting of the working group “Experimental Neuro-Oncology”
Johannes Wesling Klinikum Minden, Germany, 24–25th, April 2015

President: Bernhard Erdlenbruch, Minden
Abstracts (HTML) List of Authors
P
Erdlenbruch, B: Preface
A1
Fabian, J; Ridinger, J; Witt, O; Oehme, I: Methods to unravel the role of HDAC10 in autophagy-related drug resistance
A2
Koeneke, E; Kolbinger, F; Witt, O; Oehme, I: Hypothesis-driven “HDAC-autophagy” gene cluster to identify HDAC inhibitor treatment responsive tumor entities
A3
Ecker, J; Oehme, I; Korshunov, A; Kool, M; Kulozik, AE; Pfister, SM; Witt, O; Milde, T: Targeting MYC/HDAC2 interaction in Group 3 medulloblastoma – rationales for an innovative therapeutic approach
A4
Van Gool, SW; Dejaegher, J; De Vleeschouwer, S: Brain tumor immunotherapy. What have we learned so far?
A5
Belmans, J; Van Gool, SW: Can nanotechnology help immunotherapy in glioblastoma multiforme? Tumor protein loaded nanoparticles
A6
Lindemann, C; Marschall, V; Weigert, A; Klingebiel, T; Fulda, S: CCL2 – a critical inducer of Smac mimetic-induced migration and invasion in glioblastoma cells and its impact on the tumor microenvironment
A7
Kaina, B: Artesunate in glioblastoma therapy?
A8
Leibner, A; Selt, F; Ecker, J; Oehme, I; Kool, M; Kulozik, AE; Pfister, SM; Witt, O; Milde, T: Preclinical evaluation and translational consequences of EZH2-inhibition in malignant brain tumors
A9
Witt, O; van Tilburg, C; Worst, B; Witt, R; Jones, DT; Lichter, P; Eggert, A; Pfister, SM: The INFORM-study for personalized pediatric oncology: current status and future outlook
A10
Josupeit, R; Bender, S; Leuchs, B; Herold-Mende, C; Schlehofer, JR; Witt, O; Rommelaere, J; Jeannine Lacroix, J: Cell culture models of pediatric high-grade glioma are susceptible to parvovirus-1 induced cytotoxicity
A11
William, D; Mokri, P; Schneider, B; Classen, CF: Optimization of Glioblastoma multiforme in vitro culture conditions for preservation of EGFR gene amplification
A12
Schneider, B; William, D: Is PTEN subject to mRNA editing in glioblastoma xenografts?
A13
Selt, F; Kiss, J; Gronych, J; Jones, DTW; Brummer, T; Kulozik, AE; Pfister, SM; Milde, T; Witt, O: Preclinical model development for pilocytic astrocytoma